LY-3053102
- Generic Name
- LY-3053102
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
Phase 1
Terminated
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2013-12-25
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 60
- Registration Number
- NCT02020616
- Locations
- 🇺🇸
Orange County Research Center, Orange, California, United States
🇺🇸Compass Research, Orlando, Florida, United States
🇺🇸Clinilabs, Inc (New York), New York, New York, United States
A Study of LY3053102 in Healthy Participants
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 41
- Registration Number
- NCT01736241
- Locations
- 🇸🇬
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath